ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,127.79
      1.26%
      US Tech 100
      17,446.00
      2.17%
      Dow Jones
      38,675.68
      1.18%
      Brent Oil
      82.765
      0.00%
      Bitcoin
      63,512.14
      0.99%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Bone Biologics Corporation (BBLG)

      7. Bone Biologics Corporation (BBLG) News

      BBLG

      Bone Biologics (BBLG)

      Bone Biologics Corporation
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:BBLG
      DateTimeSourceHeadlineSymbolCompany
      03/06/20244:15PMBusiness WireBone Biologics Announces Closing of $2.0 Million Public OfferingNASDAQ:BBLGBone Biologics Corporation
      03/05/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BBLGBone Biologics Corporation
      03/04/20245:21PMEdgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:BBLGBone Biologics Corporation
      03/04/20249:15AMBusiness WireBone Biologics Announces Pricing of $2.0 Million Public OfferingNASDAQ:BBLGBone Biologics Corporation
      03/01/20248:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BBLGBone Biologics Corporation
      03/01/20248:00AMBusiness WireBone Biologics Reports Progress With NB1 Clinical ProgramNASDAQ:BBLGBone Biologics Corporation
      02/26/20244:50PMEdgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:BBLGBone Biologics Corporation
      02/23/20245:09PMEdgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:BBLGBone Biologics Corporation
      02/21/20245:05PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:BBLGBone Biologics Corporation
      02/14/20246:41PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BBLGBone Biologics Corporation
      02/14/202410:55AMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BBLGBone Biologics Corporation
      02/13/20248:03PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BBLGBone Biologics Corporation
      01/30/20245:09PMEdgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:BBLGBone Biologics Corporation
      01/25/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BBLGBone Biologics Corporation
      01/19/20245:24PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BBLGBone Biologics Corporation
      01/19/20245:22PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BBLGBone Biologics Corporation
      01/17/20245:21PMEdgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:BBLGBone Biologics Corporation
      01/12/20245:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BBLGBone Biologics Corporation
      01/11/20248:15AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BBLGBone Biologics Corporation
      01/11/20248:00AMBusiness WireBone Biologics Appoints Healthcare Finance Veteran Robert E. Gagnon to Board of DirectorsNASDAQ:BBLGBone Biologics Corporation
      01/10/20245:17PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BBLGBone Biologics Corporation
      01/10/20245:15PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:BBLGBone Biologics Corporation
      01/10/20248:15AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BBLGBone Biologics Corporation
      01/10/20248:00AMBusiness WireBone Biologics Regains Compliance with Nasdaq Continued Listing RequirementsNASDAQ:BBLGBone Biologics Corporation
      01/05/20245:15PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:BBLGBone Biologics Corporation
      01/02/20245:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BBLGBone Biologics Corporation
      01/02/20243:34PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BBLGBone Biologics Corporation
      12/20/20235:21PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BBLGBone Biologics Corporation
      12/18/20238:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BBLGBone Biologics Corporation
      12/18/20238:00AMBusiness WireBone Biologics Announces 1-for-8 Reverse Stock SplitNASDAQ:BBLGBone Biologics Corporation
       Showing the most relevant articles for your search:NASDAQ:BBLG